0001415889-23-012231.txt : 20230814
0001415889-23-012231.hdr.sgml : 20230814
20230814174959
ACCESSION NUMBER: 0001415889-23-012231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Atadja Peter
CENTRAL INDEX KEY: 0001958563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 231172384
MAIL ADDRESS:
STREET 1: 12 PENNS TRAIL
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
form4-08142023_090853.xml
X0508
4
2023-08-10
0001130598
Onconova Therapeutics, Inc.
ONTX
0001958563
Atadja Peter
C/O ONCONOVA THERAPEUTICS, INC.
12 PENNS TRAIL
NEWTOWN
PA
18940
true
false
false
false
0
Stock Option (right to purchase)
1.02
2023-08-10
4
A
0
66468
0
A
2024-08-10
2033-08-10
Common Stock
66468
66468
D
These options vest 100% on the first anniversary of the grant date.
/s/ Mark Guerin, Attorney-in-Fact
2023-08-14